A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)
CompletedOBSERVATIONAL
Enrollment
39
Participants
Timeline
Start Date
Not specified
Conditions
Non-Hodgkins Lymphoma
Interventions
DRUG
Gemcitabine
DRUG
Cisplatinum
DRUG
Rituximab
Trial Locations (1)
SM2 5PT
Royal Marsden NHS trust, Sutton
All Listed Sponsors
lead
Royal Marsden NHS Foundation Trust
OTHER
NCT00301301 - A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL) | Biotech Hunter | Biotech Hunter